Apellis Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

20.33 -1.00 (-4.69%) USD | NASDAQ | Jan 14, 16:00

20.34 +0.01 (+0.05%) Pre-Market: 08:14

View Other Long Term Liabilities (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade
Fortress Biotech, Inc.	Upgrade
Ultragenyx Pharmaceutical, Inc.	Upgrade
Fulcrum Therapeutics, Inc.	Upgrade